Nonetheless, given the current absence of data from prospective clinical trials in Chinese patients, the results accruing from this analysis provide important preliminary information for clinicians to consider future research in patients with HER2-positive advanced gastric cancer. The gene discussed is ERBB2; the disease is gastric cancer.